المؤلفون: Brigitte A. B. Essers, Nicole W.J. Kelleners-Smeets, Han P. A. van Pelt, Eefje Spoorenberg, Patricia J. F. Quaedvlieg, Joris J. Rijzewijk, Gertruud A. M. Krekels, Klara Mosterd, Michette J. M. De Rooij, Pierre A. F. A. van Neer, Aimee H.M.M. Arits, Anja Sommer, Adrienne J. van Geest, Patty J. Nelemans, P.M. Steijlen

المساهمون: MUMC+: MA Dermatologie (9), Dermatologie, MUMC+: KIO Kemta (9), Afdeling Onderwijs FHML, Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, RS: GROW - School for Oncology and Reproduction

المصدر: Lancet oncology, 14(7), 647-654. Elsevier Science
Lancet Oncology, 14(7), 647-654. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Male, Skin Neoplasms, SURGERY, medicine.medical_treatment, Administration, Topical, Imiquimod, Photodynamic therapy, GUIDELINES, law.invention, Randomized controlled trial, law, 5-PERCENT CREAM, Single-Blind Method, Aged, 80 and over, Photosensitizing Agents, Middle Aged, Prognosis, Oncology, Fluorouracil, Aminoquinolines, Female, Topical Fluorouracil, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, Antimetabolites, Antineoplastic, NONMELANOMA SKIN-CANCER, Antineoplastic Agents, medicine, Carcinoma, Humans, Adverse effect, Aged, Neoplasm Staging, business.industry, Aminolevulinic Acid, medicine.disease, Dermatology, TRENDS, Surgery, Photochemotherapy, Carcinoma, Basal Cell, 5-YEAR, Itching, business, FOLLOW-UP, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd686e3db3e9e692095c504a6352fa80
https://doi.org/10.1016/s1470-2045(13)70143-8